Abstract
Dear Editor,
The publication “Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies” is an interesting article.1 In general, elevating the tumor temperature to ≥39°C, often known as hyperthermia, exhibits potential as a supportive treatment for cancer treatments. The molecular and cellular impacts of hyperthermia are reviewed in this study. These effects include the inhibition of DNA repair enzymes, the induction of cell cycle arrest, the activation of apoptotic pathways, and the modification of heat shock protein expression. Furthermore, immune system activation, increased metabolic rates, and maybe enhanced immune checkpoint inhibitor potency are all caused by hyperthermia. Moreover, heat above 50°C can cause tumor antigens to be released, which can boost immune responses.
The absence of particular case studies or examples to back up the assertions made in this review about the impact of hyperthermia on immune system and cancer cell viability is one possible flaw. Furthermore, the lack of precise information in the study regarding the methodology employed in research pertaining to the effects of hyperthermia raises doubts regarding the validity and reliability of the results. It would be beneficial for future study to address the limits of the employed approaches and provide more detailed examples.
In the future, it could be beneficial for scientists to carry out additional clinical trials to assess the efficacy of hyperthermia as a cancer treatment adjuvant. In order to strengthen the immune response to malignancies, future research may concentrate on improving the administration of hyperthermic treatments. One such method would be the use of photothermal nanoparticles for targeted drug delivery and heating. Furthermore, investigating the synergistic effects of conventional cancer treatments or other immunotherapies in combination with heat may provide new insights. All things considered, more investigation and clinical testing are necessary to completely comprehend the advantages and restrictions of hyperthermia in cancer treatment.
Footnotes
Author Contributions
HP 50% ideas, writing, analyzing, approval.
VW 50% ideas, supervision, approval.
Data Availability Statement
There is no new data generated.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
